HealthQuill cardiovascular disease
British-Swedish AstraZeneca signed a $1.92 billion licensing agreement with CSPC Pharmaceutical Group to develop, manufacture and commercialize a compound to treat a metabolic disorder.
Drugs Health Medical

AstraZeneca in $1.92 million deal with HK-listed CSPC Pharmaceutical

British-Swedish AstraZeneca signed a $1.92 billion licensing agreement with CSPC Pharmaceutical Group to develop, manufacture and commercialize a compound to treat a metabolic.

Read More
BioNTech signs pact with Australia
Drugs Health Medical

Covid-19 vaccines increase life expectancy of heart patients, study

HQ Team May 13, 2024:  New research says Covid-19 vaccines given to people suffering from heart failure improve their chances of living longer.

Read More
obesity
Drugs Health Medical

Ultra-Processed Foods linked to over 30 adverse health outcomes

Bharti Jayshankar February 29, 2024: From packaged snacks to sugary drinks, the allure of ultra-processed foods (UPF) has become a staple in many.

Read More
AbbVie Inc., will buy Cerevel Therapeutics, developing drugs for neuroscience diseases, for $8.7 billion in a bid to boost the North Chicago, Illinois-based company’s presence in the psychiatric and neurological disorder segment.
Drugs Health Medical

The loneliness epidemic: A pervasive global health crisis

HQ Team February 21,2024: Loneliness is a pervasive epidemic affecting the youngest to the oldest, impacting their physical and mental health alike. As.

Read More
Climate Health Medical

Uncovering hidden costs of lead exposure: New study

HQ Team November 21, 2023: Lead exposure remains a significant worldwide health risk, and a study has quantified its toll on both health.

Read More
Global air pollution can aid antibiotic resistance in humans along with contaminated food and water, researchers from China and the UK found.
Climate Health Pharma

Global air pollution wrecking human resistance to antibiotics

HQ Team August 13, 2023: Global air pollution can aid antibiotic resistance in humans, researchers from China and the UK found. They checked.

Read More
Switzerland’s healthcare company, Roche, signed a pact with US-based Alnylam to jointly develop and commercialize a therapy to treat hypertension in people with high cardiovascular risk.
Drugs Health Pharma

Roche, Alnylam to jointly develop hypertension therapy

HQ Team July 25, 2023: Switzerland’s healthcare company, Roche, signed a pact with US-based Alnylam to jointly develop and commercialize a therapy to.

Read More
Eli Lilly and Company will acquire private Versanis for $ 1.93 billion in cash to expand its portfolio of obesity drugs, the Indianapolis-based company said in a statement.
Drugs Health Pharma

Eli Lilly to acquire Versanis for $1.9 billion in an obesity drug push

HQ Team July `4, 2023: Eli Lilly and Company will acquire private Versanis for $ 1.93 billion in cash to expand its portfolio.

Read More
The use of non-sugar sweeteners leads to an increased risk of type 2 diabetes, cardiovascular diseases, and mortality in adults in the long term, according to the World Health Organization.
Drugs Health Pharma

WHO advises against use of non-sugar sweeteners for weight loss, NCDs

HQ Team May 15, 2023: The use of non-sugar sweeteners leads to an increased risk of type 2 diabetes, cardiovascular diseases, and mortality.

Read More
A probe by the US-based Centres for Disease Control into the deaths of 70 children in Gambia "strongly suggests" cough syrups involving contaminated diethylene glycol and ethyl glycol, by an Indian company, were involved.
Health Medical

Eight-fold increased risk of heart attack in patients with undetected coronary condition

Researchers from the University of Copenhagen in Denmark have found asymptomatic people with undetected obstructive coronary atherosclerosis increase their risk for a heart.

Read More